Selective Androgen Receptor Modulators
(SARMs): A Mini-Review
	 Volume 1 - Issue 1
		
		Michael AB Naafs*
		
		
		
		      - 
                
				Author Information
Open or Close
                
				
				
		- Department of Endocrinology, International Health Consultancy, Netherlands
 *Corresponding author:  Michael AB Naafs, Dutch Internist Endocrinologist, Health Consultant at Naafs, International Health Consultancy,
Rhodoslaan 20, 7577KN, Oldenzaal, The Netherlands
				 
 
 
 
 
			
			
			
				Received: January 18, 2018;   Published: January 23, 2018
             
      DOI:  10.32474/OAJRSD.2018.01.000103
			 
			   		
			   
			    Full Text
			   Full Text
			   
			   
			    PDF
			   PDF
			   
			   
				To view the Full Article    Peer-reviewed Article PDF
		
		Abstract
Selective Androgen Receptor Modulators (SARMs) were discovered in the late 1990’s.They may have an application in treatments
of various diseases, including muscle wasting, cancer cachexia, breast cancer, osteoporosis, andropause and sarcopenia. In this minireview
the development, pharmacodynamics, and the phase 1 and 2 trial results of the SARMs are discussed with a special emphasis
on the illicit use of the SARMs.
        
       
		
				    
            
Abstract|
Introduction|
Preclinical and early clinical trials with SARMs|
Conclusion|
References|